scorecardresearch
Add as a preferred source on Google
Monday, December 1, 2025
TopicModerna

Topic: moderna

Even quarter dose of Moderna’s Covid vaccine induces robust immune response, study says

Researchers from a US institute inoculated 35 people with 25 micrograms of the Moderna vaccine and found antibodies six months after vaccination. Standard dose of vaccines is 100 micrograms.

No need to stop breastfeeding, study tells mothers who have received mRNA Covid shots

Researchers from University of California, San Francisco, however, say this is a preliminary study and needs to be repeated with a bigger population.

Cipla gets DCGI nod to import Moderna’s Covid vaccine for restricted emergency use in India

Permission for restricted emergency use potentially opens up a clear possibility of this vaccine being imported to India in the near future, said NITI Aayog Member Dr V K Paul.

Moderna seeks DCGI nod for its Covid vaccine in India, Cipla applies for import & sale

Moderna has also informed that the US govt has agreed to donate a certain number of doses of the Moderna vaccine through COVAX to India.

Pfizer and Moderna vaccines likely to produce long-lasting immunity, study finds

The study, published in the journal Nature, says most people vaccinated with mRNA vaccines may not need booster shots if the virus & its variants don't evolve much beyond their current forms.

In a first, rare blood clot case linked to Moderna mRNA vaccine reported in US

So far, it was thought that only adenoviral vector-based vaccines — such as the AstraZeneca vaccine — caused rare blood clots.

Moderna vaccine effective in 12-17 year-olds, could become 2nd shot approved for teens in US

Moderna says its vaccine showed 93-100% efficacy in preventing symptomatic Covid in a study of teenagers, and no significant safety concerns were observed.

59% Americans support waiving patents for Covid vaccines and life-saving drugs, survey shows

The poll also revealed that a majority of US voters want pharma giant Moderna to share the technology of its taxpayer-funded vaccine.

Modi govt wants more Covid vaccines, but Moderna is ‘not keen’ & Pfizer has this ‘condition’

CSIR has been in talks with Moderna for around 6 months but the company hasn't shown much interest. Pfizer will reassess Modi govt's latest stance on indemnifying vaccine makers.

On Camera

There’s pollution, violence, volcanic ash on my screen. And yet an email is more stressful

Years are quietly being stripped off my lifespan, and somehow that doesn’t ruin my day. But getting scolded for one careless word in an email? That can send me spiralling.

Karnataka startups feel the chill as global funding winter sets in. Fintech emerges as sole bright spot

The state raises just $2.7 billion in first nine months of 2025 compared to $4.5 billion last year, with late-stage investments hit hardest.

What’s expected from Putin’s India visit in December—Defence Secretary explains

ThePrint had previously reported that India & Russia are talking about 5 more regiments of the S-400, but no contracts are to be signed during the Russian president's visit.

Gaali cricket: Bavuma stands tall, India’s Test ego cut to size

The India-South Africa series-defining fact is the catastrophic decline of Indian red ball cricket where a visiting team can mock us with the 'grovel' word.